Synthesis, structure and catalytic properties of [Cp*Cr(C6F5)(Bn)(THF)] toward ethylene in the presence of AlEt3

Treatment of [Cp*CrCl(C₆F₅)]₂ with BnMgCl (Bn = benzyl) in Et₂O/THF affords [Cp*Cr(C₆F₅)(Bn)(THF)] (1) which has been isolated in 72% yield. This compound whose magnetic moment is equal to of 4.037 μ_B has been characterized by NMR and single crystal X-ray analysis. Compound 1 alone does not polymerize ethylene when dissolved in toluene. However, addition of excess AlEt₃ to a solution of 1 in toluene leads to a catalytically active system which readily oligomerizes ethylene under standard conditions. Oligomerization experiments carried out with [1] = 10⁻³ M and [AlEt₃] = 9 × 10⁻² M for 15 min lead to the production of ethylene oligomers with an activity of 280 kg mol Cr⁻¹ h⁻¹. The experimental molecular weight distribution observed at intermediate times during the reaction is satisfactorily accounted for by the Poisson distribution formula, which is indicative of a living polymerization system. These observations are in agreement with a catalytic cycle in which the growing alkyl chain is transferred from chromium to aluminum via a bimetallic complex in which the chromium and aluminum centers are bridged by an alkyl group and the growing polymer chain.     

Synthesis and anti-tumor activity of β-C-glycoside analogs of the immunostimulant KRN7000

A ring-closing metathesis approach was employed for the synthesis of a β-C-glycoside analog of the immunostimulant KRN7000. The protected C-glycosyl amino acid derivative 18 was converted to amino-olefin 20, and osmylation served to install the diol unit as a mixture of separable syn and anti isomers. Deprotection to the hydroxy-amine 21 was followed by N-acylation and debenzylation to deliver the target compound 5.     

Kinetics of decomposition of hydrogen peroxide on Fe(III)?Al(III) hydroxide-oxide systems

The kinetics of decomposition of hydrogen peroxide have been studied on mixed Fe(III)–Al(III) hydroxide and oxide catalysts. While iron hydroxide possesses considerable catalytic activity, aluminium hydroxide has very little activity. The rate of decomposition on mixed hydroxides increases with increasing concentration of aluminium hydroxide up to about 1.5 mol% and decreases thereafter. The mixed oxides possess negligible activity compared to the corresponding hydroxides. The energy of activation, as calculated from the Arrhenius equation, is 10.1 kcal/mol for sample S4, containing 1.52 mol% of alumina. The rate of decomposition of S4 increases with increasing pH up to 6.8 and decreases thereafter. The rate is first order in all these cases. A suitable mechanism is suggested.

---

Fe(III)–Al(III). , . , 1,5 , . . , , 10,1 / S4, 1,52 . S4 pH 6,8, . . .

     

Reaction of [CpRu(CH3CN)3]PF6 with bidentate ligands: structural characterization of [{CpRu(CH3CN)2}2(μ-η-dppe)](PF6)2 [dppe=1,2-bis(diphenylphosphino)ethane]

The reaction of [CpRu(CH₃CN)₃]PF₆ with the bidentate ligands L-L=1,2-bis(diphenylphosphino)ethane, dppe, and (1-diphenylarsino-2-diphenylphosphino)ethane, dpadppe, affords mononuclear or dinuclear complexes of formula [CpRu(η²-L-L)(CH₃CN)]PF₆, [{CpRu(CH₃CN)₂}₂(μ-η^1:1-L-L)](PF₆)₂ and [{CpRu(CH₃CN)}₂(μ-η^1:1-L-L)₂](PF₆)₂ (L-L=dppe, dpadppe). All of the compounds are characterized by microanalysis and NMR [¹H and ³¹P{¹H}] spectroscopy. The crystal structure of [{CpRu(CH₃CN)₂}₂(μ-η^1:1-dppe)](PF₆)₂ has been determined by X-ray diffraction analysis. The complex exhibits a dppe ligand bridging two CpRu(CH₃CN)₂ fragments.     

Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug

Hydroxypropyl chitosan-graft-carboxymethyl beta-cyclodextrin (HPCH-g-CM beta-CD) was synthesized by grafting CM beta-CD onto HPCH using water soluble 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) as the condensing agent. Due to the presence of hydrophobic beta-CD rings onto the HPCH backbone, this polymer can be used as a matrix for controlled drug release. The adsorption of a hydrophobic model drug, ketoprofen, by HPCH-g-CM beta-CD microparticles (using tripolyphosphate as an ionic crosslinking agent) fitted well in the Langmuir isotherm equation. The drug dissolution profile showed that HPCH-g-CM beta-CD microparticles provided a slower release of the entrapped ketoprofen than chitosan, and the release behavior was influenced by the pH value of the medium. These results suggest that beta-CD grafted with chitosan derivatives may become a potential biodegradable delivery system to control the release of hydrophobic drugs with pH-responsive capability.     

Studies on the feasibility of production of57Co by alpha bombardment of Mn and Ni targets

We have studied the feasibility of producing⁵⁷Co (271.3 d) via the⁵⁵Mn(, 2n)⁵⁷Co reaction (⁵⁵Mn–100%). The thick target yield of⁵⁷Co in the 28 to 18 MeV energy region was measured as 3.87 Ci/Ah. However, the proximity and overlap of the excitation functions for (, n), (, 2n) and (, 3n) reactions on⁵⁵Mn are such that the production of pure⁵⁷Co in high yields free of⁵⁸Co (70.8 d) and⁵⁶Co (78.8 d) has not been feasible. We have also studied a new method for ancillary production of⁵⁷Co via the reactions⁵⁸Ni(, p)⁵⁷Co and during the course of producing⁶²Zn by⁶⁰Ni(, 2n)⁶²Zn reaction. In this case the yield of⁵⁷Co of reasonable purity has been up to 1 Ci/Ah.     

Complexation of the triply-bonded dirhenium(II) complex Re(2)Cl(4)(mu-dppm)(2) (dppm = Ph(2)PCH(2)PPh(2)) by up to three acetylene molecules

The triply bonded dirhenium(II) synthons Re(2)X(4)(mu-dppm)(2) (X = Cl, Br; dppm = Ph(2)PCH(2)PPh(2)) react with acetylene at room temperature in CH(2)Cl(2) and acetone to afford the bis(acetylene) complexes Re(2)X(4)(mu-dppm)(2)(mu:eta(2),eta(2)-HCCH)(eta(2)-HCCH) (X = Cl (3), Br(4)). Compound 3 has been derivatized by reaction with RNC ligands in the presence of TlPF(6) to give unsymmetrical complexes of the type [Re(2)Cl(3)(mu-dppm)(2)(mu:eta(2),eta(2)-HCCH)(eta(2)-HCCH)(CNR)]PF(6) (R = Xyl (5), Mes (6), t-Bu (7)), in which the RCN ligand has displaced the chloride ligand cis to the eta(2)-HCCH ligand. The reaction of 3 with an additional 1 equiv of acetylene in the presence of TlPF(6) gives the symmetrical all-cis isomer of [Re(2)Cl(3)(mu-dppm)(2)(mu:eta(2),eta(2)-HCCH)(eta(2)-HCCH)(2)]PF(6) (8). The two terminal eta(2)-HCCH ligands in 8 are very labile and can be displaced by CO and XylNC to give the complexes [Re(2)Cl(3)(mu-dppm)(2)(mu:eta(2),eta(2)-HCCH)(L)(2)]Y (L = CO when Y = PF(6) (9); L = CO when Y = (PF(6))(0.5)/(H(2)PO(4))(0.5) (10); L = XylNC when Y = PF(6) (11)). These substitution reactions proceed with retention of the all-cis stereochemistry. Single-crystal X-ray structure determinations have been carried out on complexes 3, 5, 8, 10, and 11. In no instance have we found that the acetylene ligands undergo reductive coupling reactions.